Albemarle (ALB)

Geographic Segments

Business Unit / Product Segments

Major Customers (% of Revenue)

Operational KPIs

Deferred revenue (backlog)

Lithium production capacity (capacity)

Capital expenditures (capital_expenditures)

Customers (customers)

Customers served (customers_served)

Equity in net income of unconsolidated investments (equity_method_earnings)

Power capacity (generation_capacity)

Unionized Employees (headcount)

Work in process inventory (inventory_units)

Bromine produced (metal_produced)

Site acreage (net_acreage)

Lithium hydroxide supply agreement volume (orders_received)

Grade factor (ore_grade)

1.125% notes due 2025 (other)

1.625% notes due 2028 (other)

2018 Credit Agreement applicable margin (other)

2018 Credit Agreement maximum borrowings (other)

2019 Credit Facility additional borrowing capacity post-divestiture (other)

2019 Credit Facility applicable margin (other)

2019 Credit Facility maximum borrowings (other)

3.45% Senior notes due 2029 (other)

4.65% Senior notes due 2027 (other)

5.05% Senior notes due 2032 (other)

5.45% Senior notes due 2044 (other)

5.65% Senior notes due 2052 (other)

AUD/USD average rate (other)

AUD/USD spot rate (other)

Accounts payable (other)

Accounts payable to related parties (other)

Accounts payable to third parties (other)

Accounts receivable sold (other)

Accounts receivable, net (other)

Accretion of discount - Available for sale debt securities (other)

Accrued expenses (other)

Accumulated depreciation (other)

Accumulated depreciation and amortization (other)

Accumulated goodwill impairment loss (other)

Accumulated other comprehensive loss (other)

Acquired businesses share of sales (other)

Acquired revenue share (other)

Acquisition and integration costs (other)

Active Patents (other)

Active brine wells (other)

Active patents (other)

Active patents owned (other)

Additional environmental remediation exposure (other)

Additional paid-in capital (other)

Albright & Wilson shares owned (other)

Allowance for credit losses (other)

Allowance for doubtful accounts (other)

Amortization of prior service benefit - Pension (other)

Annual cost savings from separation program (other)

Annual sales rate (other)

Anticipated annual operating cost savings (other)

Applicable margin on credit facility (other)

Asia sales growth (other)

Asset retirement obligation charges (other)

Asset retirement obligations (other)

Asset value (other)

Available borrowing capacity (other)

Available borrowings (other)

Available credit capacity (other)

Available for sale debt securities (other)

Available liquidity (other)

Average interest rate (other)

Average interest rate on variable borrowings (other)

Average interest rate on variable-rate borrowings (other)

Average variable interest rate (other)

Bank guarantees and letters of credit (other)

Basic earnings per share (other)

Biocide registrations (other)

Bromide ion resource (other)

Bromine capacity increase (other)

Bromine mineral reserve estimate (other)

Bromine mineral resources (other)

Bromine reserve life (other)

Bromine reserves (other)

Bromine resource life (other)

Capital expenditure (other)

Capital expenditure forecast (other)

Capital expenditure guidance (other)

Capital expenditure incentive payables (other)

Capital expenditure plan (other)

Capital expenditures (other)

Capital expenditures included in Accounts payable (other)

Capital expenditures included in accounts payable (other)

Carrying amount of Windfield investment (other)

Carrying amount of equity interest (other)

Cash and cash equivalents (other)

Cash and cash equivalents at beginning of year (other)

Cash and cash equivalents at end of period (other)

Cash and cash equivalents decrease (other)

Cash dividends declared per share (other)

Cash flow hedge (other)

Cash flow hedge gain/loss (other)

Cash from operating activities (other)

Cash from operations (other)

Cash held by foreign subsidiaries (other)

Cash proceeds from divestitures (other)

Cash provided by operating activities (other)

Cash provided by operations (other)

Cash repatriated (other)

Catalyst industry growth rate (other)

Catalyst segment share of sales (other)

Charitable contribution (other)

China sales growth (other)

Commercial paper interest rate (other)

Commercial paper maturity (other)

Commercial paper notes maximum maturity (other)

Commercial paper notes outstanding (other)

Commercial paper outstanding (other)

Commercial paper program maximum aggregate principal (other)

Commercial paper rate (other)

Commercial paper weighted average rate (other)

Common shares outstanding (other)

Common stock (other)

Common stock dividends declared (other)

Common stock offering price per share (other)

Common stock outstanding (other)

Common stock shares issued in offering (other)

Common stock shares outstanding (other)

Common stock value (other)

Complaints (other)

Comprehensive income (other)

Comprehensive income attributable to Albemarle Corporation (other)

Comprehensive income attributable to noncontrolling interests (other)

Consolidated net funded debt to EBITDA ratio covenant (other)

Construction in progress transferred to MRL (other)

Contingent restricted stock awards outstanding (other)

Corporate assets (other)

Cost and productivity improvement (other)

Cost of goods sold (other)

Cost of goods sold correction (other)

Cost of goods sold overstatement - 2019 (other)

Cost of goods sold overstatement - 2020 (other)

Cost of goods sold overstatement - 6 months ended June 30, 2021 (other)

Cost reduction program (other)

Cost reduction run-rate savings (other)

Cost reduction savings (other)

Cost reduction target (other)

Cost savings achieved (other)

Countries served (other)

Credit agreement borrowing capacity (other)

Credit agreement outstanding (other)

Credit availability (other)

Credit facilities outstanding (other)

Credit facility availability (other)

Credit facility borrowings (other)

Credit facility borrowings outstanding (other)

Cumulative asset write-offs (other)

Cumulative contract cancellation costs (other)

Cumulative other restructuring costs (other)

Cumulative severance and employee benefits (other)

Current portion of long-term debt (other)

Customer Lists and Relationships accumulated amortization (other)

Customer Lists and Relationships gross (other)

Customer Lists and Relationships net book value (other)

DOE grant awarded (other)

Days without recordable injury (other)

Debt covenant limit (other)

Debt principal payments (other)

Debt repayment - 1.125% notes due 2025 (other)

Debt repayment - 1.875% Senior notes due 2021 (other)

Debt repayment - 2019 Credit Facility (other)

Debt repayment - 3.45% Senior notes due 2029 (other)

Debt repayment - Commercial paper notes (other)

Debt repayment - Floating rate notes due 2022 (other)

Debt to capitalization (other)

Decrease in cash and cash equivalents (other)

Deferred income taxes (other)

Deferred profits from equity method investments (other)

Deferred revenue (other)

Deferred revenue current portion (other)

Depreciation and amortization (other)

Derivative financial instruments assets (other)

Derivative financial instruments liabilities (other)

Derivative notional value (other)

Diluted earnings per share (other)

Distribution partners (other)

Distributors and reps (other)

Distributors and sales representatives (other)

Distributors and sales reps (other)

Dividend per share (other)

Dividends declared per share (other)

Dividends paid to noncontrolling interests (other)

Dividends paid to shareholders (other)

Dividends payable (other)

Dividends received from unconsolidated investments (other)

DoD critical materials award (other)

DoD funds received (other)

Early extinguishment of debt fees (other)

Earnings per share (other)

Effective income tax rate (other)

Effective tax rate (other)

Energy Storage assets (other)

Energy cost impact (other)

Energy cost increase (other)

Environmental and safety costs (other)

Environmental and safety operating costs (other)

Environmental compliance costs (other)

Environmental liabilities (other)

Environmental liabilities recorded (other)

Environmental remediation exposure (other)

Environmental remediation liability (other)

Environmental reserve charges (other)

Equity in net income of unconsolidated investments (other)

Equity method investments (other)

Executive deferred compensation plan assets (other)

Executive deferred compensation plan liabilities (other)

Expected 2021 pension contributions (other)

Expected additional decommissioning costs (other)

Expected return on assets - Pension (other)

External dilution (other)

FCC catalyst units (other)

FCC market recovery expected (other)

FCC units (other)

FCC units in operation (other)

FCC units operated (other)

FCC units operated globally (other)

FCS sale cash proceeds (other)

FCS sale preferred equity stated value (other)

FCS sale proceeds (other)

FX forward notional (other)

FX forward notional value (other)

Facility gross asset value (other)

Fair value adjustment - Available for sale debt securities (other)

Fair value of Grace preferred equity (other)

Fair value of financial instruments (other)

Fair value of foreign currency forward contracts (other)

Fair value of long-term debt (other)

Fair value of preferred equity in Grace subsidiary (other)

Fees related to early extinguishment of debt (other)

Finance lease cost (other)

Finance lease liabilities (other)

Finance lease liabilities current (other)

Finance lease liabilities noncurrent (other)

Finance lease liability (other)

Finance lease obligations (other)

Finance lease payments due (other)

Finance lease payments due 2026 (other)

Finance lease payments due 2027 (other)

Finance lease payments due 2028 (other)

Finance lease payments due 2029 (other)

Finance lease payments due remainder of 2025 (other)

Finance lease payments due thereafter (other)

Finance lease right-of-use asset (other)

Finance lease right-of-use assets (other)

Financing cash flows from finance leases (other)

Fine chemistry products (other)

First Half 2024 Restructuring reserve (other)

Foreign cash held (other)

Foreign cash held by subsidiaries (other)

Foreign currency forward contracts (other)

Foreign currency forward contracts notional (other)

Foreign currency forward contracts notional value (other)

Foreign currency forward notional (other)

Foreign currency hedge notional (other)

Foreign currency translation adjustment (other)

Foreign currency translation and other (other)

Foreign exchange transaction losses (other)

Foreign subsidiary cash (other)

Gain on sale of FCS business (other)

Gain on sale of business (other)

Goodwill (other)

Goodwill Energy Storage (other)

Goodwill Ketjen (other)

Goodwill Specialties (other)

Government grant funds received (other)

Greenbushes Mineral Resources (other)

Gross proceeds from common stock offering (other)

Gross profit (other)

Gross profit margin (other)

Groundwater inflow (other)

HPC catalyst units (other)

HPC units (other)

HPC units in operation (other)

HPC units operated (other)

HPC units operated globally (other)

Huntsman arbitration award (other)

Hydraulic conductivity (other)

IPC book-to-bill ratio (other)

Ibuprofen OTC market share (other)

Ibuprofen market share (other)

Imputed interest on finance leases (other)

Imputed interest on leases (other)

Imputed interest on operating leases (other)

Income before equity in net income of unconsolidated investments (other)

Income before income taxes and equity in net income of unconsolidated investments (other)

Income recognized in OCI - Cash flow hedge (other)

Income tax benefit - Interest rate swap (other)

Income tax expense (other)

Income tax expense - Foreign currency translation (other)

Income taxes payable (other)

Increase in cash and cash equivalents (other)

Indicated mineral resources (other)

Inferred mineral resources (other)

Inferred resources (other)

Intangible assets net (other)

Intangible assets, net (other)

Interest and financing expenses (other)

Interest cost - Pension (other)

Interest cost - Postretirement (other)

Interest rate swap (other)

Interest rate swap gain/loss (other)

Interest rate swap notional (other)

Interest-free loan (other)

Internal dilution (other)

Intra-entity profit in inventory (other)

Intra-entity profit on inventory (other)

Inventories (other)

Inventory balance (other)

Inventory valuation adjustments (other)

Inventory valuation adjustments balance (other)

Inventory valuation charge (other)

Investments (other)

Investments in equity and other corporate investments (other)

Investments in equity method investees Energy Storage (other)

Investments in equity method investees Ketjen (other)

Investments under executive deferred compensation plan (other)

Japanese yen forward contracts (other)

Joint venture loan guarantee (other)

Kemerton Train I commercial sales start (other)

Kemerton Train I completion expected (other)

Kemerton Train II commercial sales start (other)

Kemerton Train II completion expected (other)

Ketjen assets (other)

Lease liabilities (other)

Lease right-of-use assets (other)

Legal accrual - Huntsman arbitration (other)

Liabilities related to uncertain tax positions (other)

Life of mine (other)

Lithium market index increase (other)

Lithium mineral resources (other)

Lithium quota remaining (other)

Lithium remaining under Chile contract (other)

Lithium resources (other)

Lithium under Chile contract (other)

Long-lived assets (other)

Long-term debt (other)

Long-term debt carrying amount (other)

Long-term debt fair value (other)

Long-term debt noncurrent (other)

Long-term debt outstanding (other)

Long-term debt to capitalization (other)

Long-term debt to total capitalization (other)

Long-term debt, less current portion (other)

Loss on early extinguishment of debt (other)

Loss on sale of PP&E (other)

Loss on sale of interest in properties (other)

Loss recognized in Other income, net (other)

Mandatory convertible preferred shares outstanding (other)

Mandatory convertible preferred stock value (other)

Manufacturing cost reductions (other)

Manufacturing cost savings (other)

Manufacturing cost savings program (other)

Manufacturing inquiries received (other)

Market value of equity (other)

Measured and indicated resources (other)

Measured mineral resources (other)

Merger termination fee (other)

Mineral extraction facilities (other)

Mineral resources (other)

Mineral resources (exclusive of reserves) (other)

Molybdenum price (other)

Naproxen market share (other)

Natural gas hedge contracts (other)

Natural gas hedged (other)

Natural gas hedges outstanding (other)

Natural gas price range (other)

Net cash proceeds from FCS sale (other)

Net cash provided by financing activities (other)

Net cash provided by operating activities (other)

Net cash settlements of derivatives (other)

Net cash used in financing activities (other)

Net cash used in investing activities (other)

Net current assets (other)

Net effect of foreign exchange on cash (other)

Net income (other)

Net income attributable to Albemarle Corporation (other)

Net income attributable to noncontrolling interests (other)

Net income margin (other)

Net investment hedge (other)

Net price change (other)

Net proceeds from common stock offering (other)

Net property, plant and equipment (other)

Net sales (other)

Net sales pricing impact (other)

Net sales volume impact (other)

New business inquiries (other)

New product revenue growth (other)

New product revenue share (other)

New product sales (other)

New product sales growth (other)

New product sales share (other)

New products share of net sales (other)

Non-cash proceeds from divestitures (other)

Non-cash transfer of Kemerton construction in progress (other)

Non-cash transfer of construction in progress (other)

Non-pharmaceutical products in development (other)

Non-routine labor costs (other)

Noncontrolling interests (other)

Number of Reportable Segments (other)

OTC analgesic market share (other)

Obligations under executive deferred compensation plan (other)

Occupational injury and illness rate (other)

Off-balance sheet arrangements (other)

One-time transition tax reclassification (other)

Operating cash flow (other)

Operating cash flows from finance leases (other)

Operating cash flows from operating leases (other)

Operating lease cost (other)

Operating lease liabilities (other)

Operating lease liabilities current (other)

Operating lease liabilities noncurrent (other)

Operating lease liability (other)

Operating lease payments due (other)

Operating lease payments due 2026 (other)

Operating lease payments due 2027 (other)

Operating lease payments due 2028 (other)

Operating lease payments due 2029 (other)

Operating lease payments due remainder of 2025 (other)

Operating lease payments due thereafter (other)

Operating lease right-of-use asset (other)

Operating lease right-of-use assets (other)

Operating profit (other)

Operating profit margin (other)

Ordinary shares on issue (other)

Other accounts receivable (other)

Other assets (other)

Other comprehensive income - Cash flow hedge (other)

Other comprehensive income - Interest rate swap (other)

Other comprehensive loss (other)

Other comprehensive loss - Foreign currency translation (other)

Other comprehensive loss attributable to noncontrolling interests (other)

Other credit line availability (other)

Other current assets (other)

Other debt repayments (other)

Other debt repayments, net (other)

Other expense, net (other)

Other income, net (other)

Other intangibles (other)

Other intangibles accumulated amortization (other)

Other intangibles gross (other)

Other intangibles net book value (other)

Other intangibles, net (other)

Other intangibles, net of amortization (other)

Other lines of credit availability (other)

Other long-term debt (other)

Other non-cash items (other)

Other noncurrent liabilities (other)

Ownership interest (other)

Patent Applications (other)

Patent Applications Pending (other)

Patent applications pending (other)

Patents (other)

Patents Owned (other)

Patents and Technology accumulated amortization (other)

Patents and Technology gross (other)

Patents and Technology net book value (other)

Patents issued (other)

Patents issued in 2003 (other)

Patents obtained via acquisitions (other)

Patents owned (other)

Payables to unconsolidated affiliates (other)

Pending Patent Applications (other)

Pending patent applications (other)

Pension and postretirement benefit expense (other)

Pension and postretirement contributions (other)

Pension benefits (other)

Pension benefits cost (credit) (other)

Pension contributions (other)

Pension discount rate (other)

Pension plan contributions (other)

Performance unit awards outstanding (other)

Pharmaceutical pipeline products (other)

Pollution abatement capex (other)

Polymer Additives products (other)

Postretirement benefit premiums (other)

Postretirement benefit premiums paid (other)

Postretirement benefits (other)

Postretirement benefits cost (other)

Potential additional environmental remediation costs (other)

Pre-commercial pipeline (other)

Pre-commercial product pipeline (other)

Preferred equity dividend rate (other)

Pricing change (other)

Private equity securities (other)

Private equity securities measured at net asset value (other)

Proceeds from borrowings of credit agreements (other)

Proceeds from exercise of stock options (other)

Proceeds from issuance of common stock (other)

Product registrations pending (other)

Product share of net sales (other)

Production and R&D facilities (other)

Production and utility costs - winter storm (other)

Products in development pipeline (other)

Property, plant and equipment gross (other)

Property, plant and equipment net (other)

Property, plant and equipment, at cost (other)

Property, plant and equipment, net (other)

Proven bromine reserve life (other)

Proven bromine reserves (other)

Public equity securities (other)

Purchases from unconsolidated affiliates (other)

Quarterly dividend per share (other)

R&D department spending (other)

R&D expense (other)

R&D expense ratio (other)

R&D percent of net sales (other)

R&D spending (other)

Rainfall (other)

Raw material and energy cost inflation (other)

Raw material cost impact (other)

Raw material cost increase (other)

Receivables from unconsolidated affiliates (other)

Recorded amount of long-term debt (other)

Recorded environmental liabilities (other)

Recorded environmental liability (other)

Refineries worldwide (other)

Related party payables (other)

Related party purchases (other)

Related party receivables (other)

Related party sales (other)

Remaining lithium quota (other)

Remaining lithium sales rights (other)

Remaining repurchase authorization (other)

Repatriated cash from foreign subsidiaries (other)

Repayments of long-term debt (other)

Repurchase authorization remaining (other)

Research and development expense (other)

Research and development expenses (other)

Research and development spending (other)

Resource life (other)

Restricted stock awards outstanding (other)

Restructuring costs (other)

Restructuring reserve (other)

Retained earnings (other)

Revenue foreign currency impact (other)

Revenue from recent acquisitions (other)

Revenue from recent products (other)

Revenue price/mix change (other)

Revenue volume change (other)

Revolver availability (other)

Right-of-use assets obtained (other)

Right-of-use assets obtained for operating leases (other)

SG&A and R&D as % of net sales (other)

SG&A and R&D percent of sales (other)

SG&A expense ratio (other)

SG&A percent of net sales (other)

SG&A plus R&D expense ratio (other)

Salar de Atacama Mineral Resources (other)

Sales from new products (other)

Sales of marketable securities (other)

Sales of marketable securities, net (other)

Sales to unconsolidated affiliates (other)

Second Half 2024 Restructuring reserve (other)

Selected distributors (other)

Selling, general and administrative expenses (other)

Service cost - Pension (other)

Service cost - Postretirement (other)

Share repurchase authorization remaining (other)

Shareholders of record (other)

Shares authorized for repurchase (other)

Shares available for grant (other)

Shares available for repurchase (other)

Shares outstanding (other)

Shares remaining for repurchase (other)

Shares repurchased (other)

Short-term lease cost (other)

Silver Peak Mineral Resources (other)

Silver Peak resource life (other)

Specialties assets (other)

Stock options exercisable (other)

Stock options outstanding (other)

Stock repurchase authorization (other)

Stock-based compensation (other)

Sustainable cost savings (other)

Tax benefit - Huntsman arbitration (other)

Tax expense - out-of-period adjustment (other)

Tax expense on FCS gain (other)

Tax indemnification liability (other)

Tax payments increase (other)

Tender offer participation (other)

Tender offer price (other)

Tianyuan acquisition price (other)

Total Albemarle Corporation shareholders’ equity (other)

Total R&D department spending (other)

Total R&D spending (other)

Total assets (other)

Total current assets (other)

Total current liabilities (other)

Total equity (other)

Total intangible assets accumulated amortization (other)

Total intangible assets gross (other)

Total intangible assets net book value (other)

Total investments in equity method investees (other)

Total lease cost (other)

Total lease payments (other)

Total liabilities (other)

Total liabilities and equity (other)

Total long-term debt (other)

Total mineral reserves (other)

Total net income (other)

Total net pension and postretirement benefits credit (other)

Total segment assets (other)

Trade Names and Trademarks accumulated amortization (other)

Trade Names and Trademarks gross (other)

Trade Names and Trademarks net book value (other)

Trade accounts receivable (other)

Transition tax on foreign earnings (other)

U.S. unionized workforce (other)

Unamortized discount and debt issuance costs (other)

Uncertain tax position liability (other)

Uncertain tax positions liability (other)

Union or works council representation (other)

Union representation (other)

Union-represented employees (other)

Unionized US employees (other)

Unionized employees (other)

Unrealized gain on investments (other)

Unrealized gain on investments in marketable securities (other)

Unrecognized tax benefits (other)

Unrecognized tax benefits liability (other)

Unused credit capacity (other)

Variable interest rate borrowings (other)

Variable lease cost (other)

Variable rate borrowing rate (other)

Variable rate borrowings (other)

Variable rate borrowings outstanding (other)

Variable-rate borrowings (other)

Variable-rate borrowings outstanding (other)

Variable-rate debt weighted average interest rate (other)

Variable-rate foreign bank loans (other)

Volume change (other)

Weighted average diluted shares (other)

Weighted average discount rate (other)

Weighted average interest rate (other)

Weighted average remaining lease term (other)

Weighted average shares (other)

Weighted average shares outstanding (other)

Weighted-average common shares outstanding (other)

Weighted-average common shares outstanding - basic (other)

Weighted-average common shares outstanding - diluted (other)

Weighted-average diluted shares (other)

Weighted-average interest rate (other)

Weighted-average shares outstanding (other)

Windfield equity interest (other)

Windfield joint venture carrying amount (other)

Windfield joint venture net income (other)

Windfield joint venture net sales (other)

Withholding taxes paid on stock-based compensation (other)

Wodgina Mineral Resources (other)

Wodgina mine production restart expected (other)

Wodgina ownership interest (other)

Workforce reduction liability (other)

Working capital changes (other)

Working capital outflow improvement (other)

Year 2000 program cost (other)

Year 2000 project cost (other)

Year 2000 project cost expended (other)

Year 2000 project estimated total cost (other)

Lithium mineral reserves (probable_reserves)

Ore processed (production_volume)

Facilities (properties)

Bromine Reserves - Proven (proved_developed_reserves)

Total Bromine reserves (proved_reserves)

Mining recovery (recovery_rate)

Accommodation capacity (rooms)

Environmental incidents (safety_incidents)

Site area (square_footage)

OSHA Recordable Injury Rate (trir)

Units shipped (units_shipped)

Manufacturing capacity utilization (utilization_rate)

Water reused (water_consumption)

Workforce Totals

Demographics

Workforce Breakdowns

HCM Metrics — Point-in-Time

HCM Metrics — Flow (Annual / YTD)

Workforce Actions